FF91 Liberate-D
About this episode
The episode discusses the LIBERATE-D trial and its implications for dialysis strategies in acute kidney injury.
The Filtrate Joel Topf kidneyboy.bsky.social Pedro Teixeira @nephcrit.bsky.social Nayan Arora @captainchloride.bsky.social Anna Gaddy @annagaddy.bsky.social Swapnil Hiremath @hswapnil.medsky.social and on LinkedIn Special Guests Ian McCoy, MD @NephroNinja study author and UCSF Chi-yuan Hsu Senior author and Chief of the Division of Nephrology at UCSF Samuel Silver Associate Professor at Queens University in Canada Editing Vipin Verghese and Joel Topf Show Notes NephJC Discusion: Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D Manuscript: A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial JAMA | PubMed Ben’s pilot study: RAD-AKI Pilot study: Recovery After Dialysis-Requiring Acute Kidney Injury (RAD-AKI) ( ClinicalTrials.gov ) STARRT-AKI NephJC Editorial in JAMA: A-E-I-O-U and Sometimes Why—Dialysis in Acute Kidney Injury ( JAMA ) What Is Dialytrauma? ( Nephrology Times ) How Fragile Are the Results of a Trial? The Fragility Index ( PubMedCentral ) Shiffl Trial: Daily Hemodialysis and the Outcome of Acute Renal Failure ( NEJM ) AKIKI: Initiation…
More episodes of Freely Filtered, a NephJC Podcast
- FF90 NephMadness 2026: Animal House
- FF 89 Top Stories of 2025
- FF 86 Atacicept for IgAN. Third attempt
- FF 88 BICARICU-2, Bicarbonate in the ICU, still not helpful?
- FF 87 Can Fish Oil Knock the Crap out of Dialysis Associated CV Disease?
- FF 86 Atacicept for IgAN with Jon Barratt
Explore listener stats, chart rankings, contacts and more on the Freely Filtered, a NephJC Podcast podcast page.